These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 661303)

  • 21. Cancer: An unexpected addiction.
    Shaughnessy JD
    Nature; 2008 Jul; 454(7201):172-3. PubMed ID: 18615074
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiple myeloma.
    Zyla G
    InTouch; 2002 Sep; 4(5):18-22. PubMed ID: 12398055
    [No Abstract]   [Full Text] [Related]  

  • 23. [Molecular oncogenesis of multiple myeloma].
    Furukawa Y
    Rinsho Ketsueki; 2013 Oct; 54(10):1867-75. PubMed ID: 24064838
    [No Abstract]   [Full Text] [Related]  

  • 24. [Multiple myeloma and the kidneys].
    Kamaeva OI
    Ter Arkh; 1997; 69(6):73-5. PubMed ID: 9297284
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma cell neoplasms. Review of disease progression and report of a new variant.
    Nolan KD; Mone MC; Nelson EW
    Surg Oncol; 2005 Aug; 14(2):85-90. PubMed ID: 15993050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple myeloma--an update on diagnosis and treatment.
    Caers J; Vande broek I; De Raeve H; Michaux L; Trullemans F; Schots R; Van Camp B; Vanderkerken K
    Eur J Haematol; 2008 Nov; 81(5):329-43. PubMed ID: 18637123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activin A induces apoptotic cell death of myeloma cells].
    Yamato K; Koseki T; Kisaki M; Ikeda Y; Nishihara T
    Rinsho Ketsueki; 1996 Jul; 37(7):564-73. PubMed ID: 8779773
    [No Abstract]   [Full Text] [Related]  

  • 28. Case report of multiple myeloma and hypothyroidism in primary biliary cirrhosis.
    Rodríguez-Leal GA; Moran-Villota S; Arista-Nasr J; Uribe-Esquivel M
    Rev Invest Clin; 1997; 49(3):215-20. PubMed ID: 9294961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of chronic lymphocytic leukaemia and multiple myeloma: report of a case and review of the literature.
    Quaglino D; Paterlini P; De Pasquale A; Cretara G; Venturoni L
    Haematologica; 1982 Aug; 67(4):576-88. PubMed ID: 6815016
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies.
    Mitsiades CS; McMillin DW; Klippel S; Hideshima T; Chauhan D; Richardson PG; Munshi NC; Anderson KC
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1007-34, vii-viii. PubMed ID: 17996586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible renal insufficiency in multiple myeloma.
    Bernstein SP; Humes HD
    Arch Intern Med; 1982 Nov; 142(12):2083-6. PubMed ID: 7138157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cell transplant for first relapse from the multiple myeloma research foundation.
    Anderson KC; Vesole DH
    Oncology (Williston Park); 2006 Dec; 20(14):1818, 1820-1, 1825-6. PubMed ID: 17263130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multiple myeloma: past, present and future].
    Zulian GB
    Rev Med Suisse Romande; 1989 Nov; 109(11):939-45. PubMed ID: 2688027
    [No Abstract]   [Full Text] [Related]  

  • 35. Using genomics to identify high-risk myeloma after autologous stem cell transplantation.
    Shaughnessy JD; Barlogie B
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):77-80. PubMed ID: 16399589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Renal insufficiency due to light chain multiple myeloma].
    van Zaanen HC; Diderich PP; Pegels JG; Ruizeveld de Winter JA
    Ned Tijdschr Geneeskd; 2000 Nov; 144(45):2133-7. PubMed ID: 11086485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support.
    Boccadoro M; Omedé P; Dominietto A; Palumbo A; Bringhen S; Giaretta F; Ortolano B; Triolo S; Pileri A
    Bone Marrow Transplant; 2000 Jan; 25(1):25-9. PubMed ID: 10654010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytological and histological classification of multiple myeloma.
    Wutke K; Várbíró M; Rüdiger KD; Kelényi G
    Haematologia (Budap); 1981; 14(3):315-29. PubMed ID: 7327443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
    Jourdan M; De Vos J; Mechti N; Klein B
    Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple myeloma in the elderly.
    Cohen HJ
    Clin Geriatr Med; 1985 Nov; 1(4):827-55. PubMed ID: 3913521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.